21.80
price up icon0.51%   0.11
pre-market  시장 영업 전:  22.17   0.37   +1.70%
loading
전일 마감가:
$21.69
열려 있는:
$21.61
하루 거래량:
834.79K
Relative Volume:
0.61
시가총액:
$13.99B
수익:
$2.62B
순이익/손실:
$966.70M
주가수익비율:
14.53
EPS:
1.5004
순현금흐름:
$1.09B
1주 성능:
+3.07%
1개월 성능:
+3.02%
6개월 성능:
+3.96%
1년 성능:
-21.58%
1일 변동 폭
Value
$21.59
$21.86
1주일 범위
Value
$21.41
$22.30
52주 변동 폭
Value
$17.23
$28.56

Genmab Adr Stock (GMAB) Company Profile

Name
명칭
Genmab Adr
Name
전화
-
Name
주소
-
Name
직원
2,638
Name
트위터
@Genmab
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
GMAB's Discussions on Twitter

GMAB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GMAB
Genmab Adr
21.80 13.01B 2.62B 966.70M 1.09B 1.5004
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Genmab Adr Stock (GMAB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-01 다운그레이드 Bernstein Mkt Perform → Underperform
2025-03-11 업그레이드 William Blair Mkt Perform → Outperform
2025-02-13 업그레이드 Leerink Partners Market Perform → Outperform
2024-10-08 개시 Redburn Atlantic Buy
2024-09-04 재개 Morgan Stanley Equal-Weight
2024-08-20 다운그레이드 JP Morgan Overweight → Neutral
2024-07-15 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2024-02-23 업그레이드 BMO Capital Markets Market Perform → Outperform
2024-01-22 다운그레이드 Citigroup Neutral → Sell
2023-12-06 업그레이드 UBS Neutral → Buy
2023-11-10 업그레이드 Deutsche Bank Hold → Buy
2023-11-08 업그레이드 DNB Markets Sell → Buy
2023-10-18 개시 Exane BNP Paribas Underperform
2023-09-06 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-08-24 개시 BTIG Research Buy
2023-07-14 개시 HSBC Securities Buy
2023-05-31 개시 UBS Neutral
2023-05-12 개시 Morgan Stanley Underweight
2022-12-20 다운그레이드 Citigroup Buy → Neutral
2022-11-14 개시 William Blair Mkt Perform
2022-11-11 다운그레이드 Deutsche Bank Buy → Hold
2022-06-24 개시 BMO Capital Markets Market Perform
2022-05-02 개시 Cowen Market Perform
2022-03-16 업그레이드 UBS Neutral → Buy
2022-01-31 업그레이드 H.C. Wainwright Neutral → Buy
2022-01-03 다운그레이드 Guggenheim Buy → Neutral
2021-12-01 개시 Berenberg Sell
2021-09-16 다운그레이드 Jefferies Buy → Hold
2021-09-07 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2021-08-24 다운그레이드 H.C. Wainwright Buy → Neutral
2021-04-20 개시 Deutsche Bank Buy
2021-01-19 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-09-23 다운그레이드 Bryan Garnier Neutral → Sell
2020-09-08 개시 SVB Leerink Mkt Perform
2020-06-25 다운그레이드 Credit Suisse Outperform → Neutral
2020-04-23 개시 Credit Suisse Outperform
2020-02-24 재확인 H.C. Wainwright Buy
2020-01-13 개시 SunTrust Buy
2019-12-12 다운그레이드 Deutsche Bank Buy → Hold
2019-09-13 업그레이드 BofA/Merrill Neutral → Buy
2019-09-12 업그레이드 JP Morgan Neutral → Overweight
2019-08-12 개시 Guggenheim Buy
2019-08-12 개시 Morgan Stanley Overweight
2019-08-12 개시 RBC Capital Mkts Outperform
모두보기

Genmab Adr 주식(GMAB)의 최신 뉴스

pulisher
Jul 22, 2025

Genmab (GMAB) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Wall Street Analysts See a 39.97% Upside in Genmab (GMAB): Can the Stock Really Move This High? - Yahoo Finance

Jul 22, 2025
pulisher
Jul 19, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Purchased by Envestnet Asset Management Inc. - Defense World

Jul 19, 2025
pulisher
Jul 17, 2025

Genmab Bets On Antibody Innovations As Royalties Rule The Day - Finimize

Jul 17, 2025
pulisher
Jul 16, 2025

Genmab A/S FY2025 EPS Estimate Increased by William Blair - Defense World

Jul 16, 2025
pulisher
Jul 11, 2025

Genmab AS (ADR) (US3723032062.SG) latest stock news and headlines - yahoo.co

Jul 11, 2025
pulisher
Jul 11, 2025

Genmab A/S (NASDAQ:GMAB) Price Target Raised to $46.00 - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

Genmab and BioNTech’s Promising Cancer Trial: A Potential Game-Changer? - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

Genmab and BioNTech’s GEN1042 Study: A New Hope for Cancer Treatment? - TipRanks

Jul 10, 2025
pulisher
Jul 08, 2025

Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Jul 08, 2025
pulisher
Jul 08, 2025

Genmab and BioNTech’s Promising Immunoradiotherapy Study for Metastatic Tumors - TipRanks

Jul 08, 2025
pulisher
Jul 07, 2025

Genmab and BioNTech’s GEN1042 Study: A New Hope in Cancer Treatment - TipRanks

Jul 07, 2025
pulisher
Jul 06, 2025

Mirae Asset Global Investments Co. Ltd. Cuts Stock Position in Genmab A/S Sponsored ADR (NASDAQ:GMAB) - Defense World

Jul 06, 2025
pulisher
Jun 30, 2025

Envestnet Portfolio Solutions Inc. Sells 6,066 Shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB) - Defense World

Jun 30, 2025
pulisher
Jun 19, 2025

GAMMA Investing LLC Boosts Holdings in Genmab A/S Sponsored ADR (NASDAQ:GMAB) - Defense World

Jun 19, 2025
pulisher
Jun 15, 2025

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT) - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 02, 2025

Why Genmab Stock Smashed It On Monday - Barchart.com

Jun 02, 2025
pulisher
May 12, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

May 12, 2025
pulisher
May 09, 2025

Applied Dna Sciences Inc (APDN)’s Day in Review: Closing at 0.85, Down by -2.41 - DWinneX

May 09, 2025
pulisher
May 09, 2025

Stock Surge: Genmab ADR (GMAB) Closes at 19.42, Marking a -5.73 Increase/Decrease - DWinneX

May 09, 2025
pulisher
May 09, 2025

Market Momentum Report: Evercore Inc (EVR)’s Positive Close at 216.74 - DWinneX

May 09, 2025
pulisher
Apr 23, 2025

Investing in Take-Two Interactive Software, Inc (TTWO) Is Getting More Attractive - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Investing in Genmab ADR (GMAB): What You Must Know - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Nucor Corp (NUE) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Apr 23, 2025
pulisher
Apr 17, 2025

EWTX Stock Sees Surge of Approximately 4.24% in Last Five Days - knoxdaily.com

Apr 17, 2025
pulisher
Apr 16, 2025

GMAB or RGEN: Which Is the Better Value Stock Right Now? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 16, 2025

Should Value Investors Buy Genmab (GMAB) Stock? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

Genmab ADR (NASDAQ: GMAB) Jumps 1.19% In Recent Session. Here’s Everything You Need To Know. - Stocksregister

Apr 15, 2025
pulisher
Apr 10, 2025

AGCO Corp (AGCO) Beta Value: Understanding the Market Risk - News Heater

Apr 10, 2025
pulisher
Apr 04, 2025

Evercore Inc’s Mixed Bag: Down -29.24% in 6 Months, Down -20.22% in 30 Days - investchronicle.com

Apr 04, 2025
pulisher
Apr 04, 2025

GMAB’s Debt-to-Equity Ratio at 0.03: What It Means for Genmab ADR’s Future - investchronicle.com

Apr 04, 2025
pulisher
Apr 03, 2025

CZR Stock Sees Decline of Approximately -4.82% in Last Five Days - knoxdaily.com

Apr 03, 2025
pulisher
Apr 01, 2025

Genmab gets European approval for cervical cancer treatment - medwatch.com

Apr 01, 2025
pulisher
Mar 31, 2025

Magnite Inc (MGNI) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Mar 31, 2025
pulisher
Mar 26, 2025

DLocal Limited (DLO) Shares Decline Despite Market Challenges - The News Heater

Mar 26, 2025
pulisher
Mar 12, 2025

Genmab ADR Inc. (GMAB) Price Performance: The Role of Supply and Demand - The InvestChronicle

Mar 12, 2025
pulisher
Feb 07, 2025

Views of Wall Street’s Leading Experts on Genmab ADR - SETE News

Feb 07, 2025
pulisher
Feb 07, 2025

What is Core & Main Inc (CNM) Stock Return on Shareholders’ Capital? - SETE News

Feb 07, 2025
pulisher
Feb 07, 2025

There is no doubt that Kite Realty Group Trust (KRG) ticks all the boxes. - SETE News

Feb 07, 2025
pulisher
Jan 29, 2025

Sea Ltd ADR (NYSE: SE) Jumps 4.64%, Turning Investors Away - Stocks Register

Jan 29, 2025
pulisher
Jan 29, 2025

Does Genmab ADR (NASDAQ: GMAB) Still Look Hot This Week? - Stocks Register

Jan 29, 2025
pulisher
Jan 20, 2025

Genmab (GMAB) Upgraded to Buy: Here's What You Should Know - MSN

Jan 20, 2025
pulisher
Jan 17, 2025

GMAB vs. QGEN: Which Stock Is the Better Value Option? - MSN

Jan 17, 2025
pulisher
Jan 08, 2025

Genmab stock holds Buy rating on positive trial results - Investing.com

Jan 08, 2025
pulisher
Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024
pulisher
Nov 11, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 11, 2024
pulisher
Oct 15, 2024

Is Genmab (GMAB) Stock Undervalued Right Now? - Yahoo Finance

Oct 15, 2024
pulisher
Oct 08, 2024

Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround - Yahoo Finance

Oct 08, 2024
pulisher
Jun 27, 2024

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma - Yahoo Finance

Jun 27, 2024
pulisher
Apr 03, 2024

Genmab's 'Evolution' Continues With A $1.8 Billion Deal; But Shares Slip - Investor's Business Daily

Apr 03, 2024
pulisher
Mar 01, 2024

GMAB: Bank on the Future Returns With These 3 Biotech Stocks - StockNews

Mar 01, 2024

Genmab Adr (GMAB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
자본화:     |  볼륨(24시간):